Plasma Therapy Market Size, Share, Growth Analysis, By Type(Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin.), By Source(Autologous, and Allogenic.), By Application(Orthopedics, Sports Medicine, Cosmetic Surgery, Dermatology (Ulcer Healing), By End User(Hospitals & Clinics, and Research Institutes.), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2056 | Region: Global | Published Date: February, 2024
Pages: 242 |Tables: 122 |Figures: 77

Plasma Therapy Market Insights

Plasma Therapy Market size was valued at USD 297.6 million in 2019 and is poised to grow from USD 339.26 million in 2023 to USD 967.78 million by 2031, growing at a CAGR of 14% in the forecast period (2024-2031).

White blood cells (WBCs), red blood cells (RBCs), plasma, and platelets are known components of blood. As plasma contains a high concentration of antibodies, it can be utilized in plasma therapy to transmit the immunity of a healthy recovered individual to the patient. This therapy has been used for a very long period, mostly in orthopaedics, dermatology, and dentistry. The rise in androgenic alopecia patients worldwide is one of the key reasons expected to propel the growth of the market during the forecast period. Furthermore, it is anticipated that growing utilization platelet-rich plasma in a number of therapeutic areas may drive the market. Moreover, it is anticipated that the increase in the incidence of arthritis would moderate expansion of the market. Furthermore, the lack of reimbursement guidelines and the different costs involved with plasma therapy is also anticipated to restrain the market growth over the forecast period. Rising prevalence of sports injuries is driving the growth of the global market. Demand for the therapy has increased as a result of the increase in androgenic alopecia patients worldwide. Additionally, the rise in patients with androgenic alopecia and orthopedic disorders may present additional potential growth opportunities for the market in the coming years. However, the limited use of PRP in diabetic patients and kidney problems may pose further challenges for the growth of the market in the near future.

US Plasma Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 297.6 million

Largest Segment

Hospitals & Clinics

Fastest Growth

Hospitals & Clinics

Growth Rate

14% CAGR

Global Plasma Therapy Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Plasma Therapy Market Segmental Analysis

Global Plasma Therapy market is segmented on the basis of Type, Source, Application, End Users, and region. By Type, the market is segmented into Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin. By Source, the market is segmented into Autologous, and Allogenic. By Application, the market is segmented into Orthopaedics, Sports Medicine, Cosmetic Surgery, Dermatology (Ulcer Healing, Others), Ophthalmic Surgery, Neurosurgery, General Surgery, Others. By End User, the market is segmented into Hospitals & Clinics, and Research Institutes. The market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on region.

Plasma Therapy Market Analysis by Type

Due to its widespread use in tissue regeneration, repair, and healing, pure platelet-rich plasma held the largest revenue share of over 50.0% in 2021. Due to allergic and immune responses after treatments, PRP does have a low risk of unwanted effects. It is mostly known for its off-label use, and manufacturers are eager to develop new products that are expected to accelerate the industry's growth. The growing utility of leucocytes in general surgery, orthopedics, and sports injuries suggests that the leucocyte-rich segment could expand. The efficacy of LR-PRP in treating osteoarthritis of the knee with operation and bone regeneration has been established through research, and this is expected to drive new markets during the forecast period.

Plasma Therapy Market Analysis by End User

In 2021, the hospitals segmented contributed more than 45.0% of total revenue. This can be linked to a quick uptake of PRP-based therapies in hospitals as a result of the recent increase in osteoarthritis cases, increased demand for non-surgical management in therapy, and rising hair loss incidences. With installation of centrifuge systems in hospitals provided by companies like Focus Technology Co. and Changsha Biomed Supply Co., lucrative opportunities for market growth are further expanded.

Global Plasma Therapy Market By End User

To get detailed analysis on other segments, Request For Free Sample Report

Plasma Therapy Market Regional Insights

Due to the existence of top platelet-rich plasma therapy product manufacturers, active involvement of academic and research institutions in trying to cut research and development activities, rising public awareness of the benefits of platelet-rich plasma therapies, and support from regulatory bodies and the government to promote the use of PRP for medical purposes, North America held the largest market share for plasma therapy in 2021. The availability of highly skilled individuals and the region's well-developed healthcare infrastructure both drive market growth.

The market in Asia Pacific is expected to grow at the fastest CAGR, owing to high population density and the rising prevalence of chronic diseases. Huge market opportunities are being created by the expansion of healthcare facilities and government efforts to enhance public health. A major factor in the expansion of the regional market is the abundance of disease patients in the region. The market in Asia-Pacific is also growing as a result of an increase in investment by the key industry players in the region.

Global Plasma Therapy Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Plasma Therapy Market Dynamics

Plasma Therapy Market Drivers

Increasing platelet-rich plasma

  • The utilization of platelet-rich plasma is increasing as a result of increasing sports injury rates and an increase in cosmetic surgery, as well as growing participation in sporting activities. The rise of the industry is also driven by a increase in the use of platelet rich plasma (PRP) in research.

Global growth of immunoglobulin utilization

  • The demand for immunoglobulin therapy has increased as individuals become more aware of the cutting-edge procedures used in the healthcare industry. As a result, society has adopted the use of immunoglobulin for treating a variety of illnesses that are becoming increasingly prevalent in the population.

Plasma Therapy Market Restraints

The cost of plasma therapy becomes high.

  • The market growth is anticipated to be restricted by plasma therapy's high cost. The cost of plasma extraction from blood and the storage of collected plasma is imiting market expansion. In undeveloped and developing regions, the cost of therapy has limited its use. One of the main things stopping the market from expanding is that the average person cannot afford the therapy.

Request Free Customization of this report to help us to meet your business objectives.

Plasma Therapy Market Competitive Landscape

Global plasma therapy market's competitive landscape provides information by competitors. An overview of the company, financials, revenue, market potential, R&D investments, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product breadth and depth, and application dominance are among the data that are included. Only the market emphasis on plasma therapy that the companies have is covered by the data points given above.

Plasma Therapy Market Top Player’s Company Profiles

  • Biotest AG
  • CSL Behring
  • Grifols S.A.
  • Kedrion S.p.A.
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Zimmer Biomet
  • Baxter International Inc.
  • China Biologic Products Holdings, Inc.
  • GC Pharma
  • Green Cross Corp.
  • Japan Blood Products Organization
  • LFB SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • China National Biotec Group Co., Ltd. (CNBG)
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  • Jiangxi Boya Bio-Pharmaceutical Co., Ltd.
  • Bio Products Laboratory Ltd. (BPL)
  • BioLife Plasma Services
  • Canadian Plasma Resources

Plasma Therapy Market Recent Developments

  • In 2021, In order to fulfil the rising demand for plasma-related therapies, BioLife Plasma Services (US) constructed a new plasma centre in Worcester.
  • In 2021, In the Czech Republic, Biotest AG (Germany) opened its sixth plasma collecting facility. the development of new facilities to guarantee a long-term plasma supply.

Plasma Therapy Key Market Trends

  • The rise in patients with androgenic alopecia and orthopedic disorders may present additional potential growth opportunities for the plasma therapy market in the coming years. However, the limited use of PRP in diabetic patients and kidney problems may pose further challenges to the growth of the market in the near future. The healthcare company's access to trying to cut treatment options - The number of available treatments has considerably risen as a result of the healthcare industry's continued advancement. This has aided the consumers in choosing a treatment choice that is appropriate for their level of disposable income. Numerous services offered by both the public and private sectors have also assisted the healthcare industry in improving its success rate, even with relation to rare disorders. The success rate for treating rare diseases has increased as a result of the faster progress being made in the field of healthcare technology and tools.

Plasma Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to global plasma therapy market analysis, global market growth is anticipated to be driven by rising autoimmune diseases among the older population. Additionally, it is anticipated that a surge in the establishment of plasma collection centres at various locations and initiatives by healthcare organisations and governmental bodies to improve awareness about plasma donation will boost the market's revenue. Such efforts on the part of the government and businesses will accelerate the growth of the market. A lifestyle which involves alcohol, smoking, and consuming fast food increases people's chance of developing inflammatory illnesses, which is expected to boost the market growth.

Report Metric Details
Market size value in 2023 USD 297.6 million
Market size value in 2031 USD 967.78 million
Growth Rate 14%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Type
    • Pure Platelet Rich Plasma, Leukocyte Rich Platelet Rich Plasma, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin.
  • Source
    • Autologous, and Allogenic.
  • Application
    • Orthopedics, Sports Medicine, Cosmetic Surgery, Dermatology (Ulcer Healing, Others), Ophthalmic Surgery, Neurosurgery, General Surgery, Others.
  • End User
    • Hospitals & Clinics, and Research Institutes.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Biotest AG
  • CSL Behring
  • Grifols S.A.
  • Kedrion S.p.A.
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Zimmer Biomet
  • Baxter International Inc.
  • China Biologic Products Holdings, Inc.
  • GC Pharma
  • Green Cross Corp.
  • Japan Blood Products Organization
  • LFB SA
  • Shanghai RAAS Blood Products Co., Ltd.
  • China National Biotec Group Co., Ltd. (CNBG)
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
  • Jiangxi Boya Bio-Pharmaceutical Co., Ltd.
  • Bio Products Laboratory Ltd. (BPL)
  • BioLife Plasma Services
  • Canadian Plasma Resources
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Plasma Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Plasma Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Plasma Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Plasma Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Plasma Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Plasma Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Plasma Therapy Market size was valued at USD 297.6 million in 2019 and is poised to grow from USD 339.26 million in 2023 to USD 967.78 million by 2031, growing at a CAGR of 14% in the forecast period (2024-2031).

plasma therapy market's competitive landscape provides information by competitors. An overview of the company, financials, revenue, market potential, R&D investments, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launches, product breadth and depth, and application dominance are among the data that are included. Only the market emphasis on plasma therapy that the companies have is covered by the data points given above. 'Biotest AG', 'CSL Behring', 'Grifols S.A.', 'Kedrion S.p.A.', 'Octapharma AG', 'Takeda Pharmaceutical Company Limited', 'Zimmer Biomet', 'Baxter International Inc.', 'China Biologic Products Holdings, Inc.', 'GC Pharma', 'Green Cross Corp.', 'Japan Blood Products Organization', 'LFB SA', 'Shanghai RAAS Blood Products Co., Ltd.', 'China National Biotec Group Co., Ltd. (CNBG)', 'Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.', 'Jiangxi Boya Bio-Pharmaceutical Co., Ltd.', 'Bio Products Laboratory Ltd. (BPL)', 'BioLife Plasma Services', 'Canadian Plasma Resources'

The utilization of platelet-rich plasma is increasing as a result of increasing sports injury rates and an increase in cosmetic surgery, as well as growing participation in sporting activities. The rise of the industry is also driven by a increase in the use of platelet rich plasma (PRP) in research.

The rise in patients with androgenic alopecia and orthopedic disorders may present additional potential growth opportunities for the plasma therapy market in the coming years. However, the limited use of PRP in diabetic patients and kidney problems may pose further challenges to the growth of the market in the near future. The healthcare company's access to trying to cut treatment options - The number of available treatments has considerably risen as a result of the healthcare industry's continued advancement. This has aided the consumers in choosing a treatment choice that is appropriate for their level of disposable income. Numerous services offered by both the public and private sectors have also assisted the healthcare industry in improving its success rate, even with relation to rare disorders. The success rate for treating rare diseases has increased as a result of the faster progress being made in the field of healthcare technology and tools.

Due to the existence of top platelet-rich plasma therapy product manufacturers, active involvement of academic and research institutions in trying to cut research and development activities, rising public awareness of the benefits of platelet-rich plasma therapies, and support from regulatory bodies and the government to promote the use of PRP for medical purposes, North America held the largest market share for plasma therapy in 2021. The availability of highly skilled individuals and the region's well-developed healthcare infrastructure both drive market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Plasma Therapy Market

Report ID: SQMIG35H2056

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE